• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed - Authors' reply.

作者信息

Zlotta Alexandre R, Lajkosz Katherine, Efstathiou Jason A

机构信息

Division of Urology, Department of Surgery, Mount Sinai Hospital, Sinai Health System, University of Toronto, Toronto, ON M5T 3L9, Canada; Division of Urology, Department of Surgical Oncology, University Health Network, Toronto, ON, Canada.

Department of Biostatistics, University Health Network, Toronto, ON, Canada.

出版信息

Lancet Oncol. 2023 Aug;24(8):e325-e326. doi: 10.1016/S1470-2045(23)00322-4.

DOI:10.1016/S1470-2045(23)00322-4
PMID:37541276
Abstract
摘要

相似文献

1
Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed - Authors' reply.根治性膀胱切除术与肌肉浸润性膀胱癌的三联疗法：仍需进一步广泛评估——作者回复
Lancet Oncol. 2023 Aug;24(8):e325-e326. doi: 10.1016/S1470-2045(23)00322-4.
2
Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed.根治性膀胱切除术与肌肉浸润性膀胱癌的三联疗法：需要进一步广泛评估。
Lancet Oncol. 2023 Aug;24(8):e324. doi: 10.1016/S1470-2045(23)00321-2.
3
[Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer].[根治性膀胱切除术与三联疗法治疗肌层浸润性膀胱癌]
Strahlenther Onkol. 2023 Sep;199(9):871-873. doi: 10.1007/s00066-023-02134-1. Epub 2023 Aug 2.
4
Targeting barriers to wider use of trimodality therapy in localized muscle invasive bladder cancer.针对局部肌肉浸润性膀胱癌中三模态治疗广泛应用的障碍。
Urol Oncol. 2023 Jan;41(1):35-38. doi: 10.1016/j.urolonc.2020.10.005. Epub 2020 Nov 3.
5
Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.当代及新兴的肌层浸润性膀胱癌保膀胱三联疗法。
Hematol Oncol Clin North Am. 2021 Jun;35(3):567-584. doi: 10.1016/j.hoc.2021.02.006. Epub 2021 Apr 15.
6
Re: Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis.回复：根治性膀胱切除术与三联疗法治疗肌层浸润性膀胱癌：一项多机构倾向评分匹配及加权分析
Eur Urol. 2023 Dec;84(6):602-603. doi: 10.1016/j.eururo.2023.06.026. Epub 2023 Jul 12.
7
Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer: a qualitative study exploring patient priorities and counselling needs when making a treatment choice.根治性膀胱切除术或三联疗法治疗肌层浸润性膀胱癌：一项探索患者在做出治疗选择时的优先事项和咨询需求的定性研究。
BMC Cancer. 2024 Jan 31;24(1):160. doi: 10.1186/s12885-024-11927-1.
8
Re: Alexandre R. Zlotta, Leslie K. Ballas, Anderzej Niemierko, et al. Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis. Lancet Oncol 2023;24:669-81.回复：亚历山大·R·兹洛塔、莱斯利·K·巴拉斯、安杰伊·涅米尔科等人。根治性膀胱切除术与三联疗法治疗肌层浸润性膀胱癌：一项多机构倾向评分匹配和加权分析。《柳叶刀·肿瘤学》2023年；24卷：669 - 81页。
Eur Urol. 2024 Jan;85(1):e24. doi: 10.1016/j.eururo.2023.07.019. Epub 2023 Aug 31.
9
Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.膀胱癌保留膀胱的三联疗法治疗肌层浸润性膀胱癌。
Curr Oncol Rep. 2018 Jun 30;20(9):66. doi: 10.1007/s11912-018-0711-0.
10
Radical Cystectomy and the Multidisciplinary Management of Muscle-Invasive Bladder Cancer.根治性膀胱切除术与肌层浸润性膀胱癌的多学科管理
JAMA Oncol. 2016 Jul 1;2(7):855-6. doi: 10.1001/jamaoncol.2016.0149.

引用本文的文献

1
Eligibility and Endpoints for Clinical Trials in Trimodality Therapy for Bladder Cancer.膀胱癌三联疗法临床试验的入选标准和终点指标
Bladder Cancer. 2024 Oct 23;10(3):199-213. doi: 10.3233/BLC-240036. eCollection 2024.